Almeida-Porada G, Brown R L, MacKintosh F R, Zanjani E D
Department of Veterans Affairs Medical Center, University of Nevada Reno, 89520, USA.
J Hematother Stem Cell Res. 2000 Oct;9(5):683-93. doi: 10.1089/15258160050196722.
To develop culture conditions devoid of serum that would support the ex vivo expansion and maintenance of hematopoietic stem cells (HSC) with engraftment capability, we performed in vitro studies in which phenotypic and functional expansion of putative HSC populations were evaluated. We then used the human-sheep xenograft model to evaluate the engraftment potential of the ex vivo expanded cells. Adult human bone marrow CD34+-enriched cells were cultured in QBSF-60 for 14 days with or without fetal bovine serum (FBS) in the presence of interleukin-3 (IL-3), IL-6, and stem cell factor (SCF), and analyzed at days 0, 3, 7, and 14 for expansion, phenotype, clonogenic ability, and cell cycling status. Although there was a progressive expansion of numbers of cells in both groups, the group cultured with serum exhibited more than twice the expansion seen in the group without serum at all time points. The phenotypic analysis of the cultured cells showed an increase in the absolute numbers of CD34+ cells in both groups. However, when we evaluated the presence of CD34+CD38- cells, this population persisted in significantly higher numbers in the group cultured without serum, with maximal output of CD34+CD38- cells seen at 3 and 7 days. A higher total clonogenic potential was found in the serum-free cultures. To evaluate the in vivo engraftment potential of these cultured cells, 19 sheep fetuses were each injected i.p. with 9 x 10(5) cells either fresh or cultured in the conditions described above. Although all the transplanted fetal sheep showed the presence of human cells in their bone marrow (BM), the highest levels of long-term engraftment in primary recipients were obtained with the fraction of cells cultured for 3 days followed by 7 days in the absence of serum. In the secondary sheep recipients, the highest level of long-term engraftment was also achieved in sheep that received cells from primary recipients that had received cultured cells in serum-free conditions for 3 days.
为了开发无血清的培养条件,以支持具有植入能力的造血干细胞(HSC)的体外扩增和维持,我们进行了体外研究,评估假定的HSC群体的表型和功能扩增。然后,我们使用人-羊异种移植模型评估体外扩增细胞的植入潜力。将富集成人骨髓CD34 +的细胞在QBSF - 60中培养14天,在有或无胎牛血清(FBS)的情况下,添加白细胞介素-3(IL - 3)、IL - 6和干细胞因子(SCF),并在第0、3、7和14天分析细胞的扩增、表型、克隆形成能力和细胞周期状态。尽管两组细胞数量都有逐渐增加,但在所有时间点,有血清培养组的扩增倍数是无血清培养组的两倍多。培养细胞的表型分析显示两组中CD34 +细胞的绝对数量均增加。然而,当我们评估CD34 + CD38 -细胞的存在时,无血清培养组中该群体的数量持续显著更高,在第3天和第7天观察到CD34 + CD38 -细胞的最大产量。无血清培养物中发现了更高的总克隆形成潜力。为了评估这些培养细胞的体内植入潜力,向19只绵羊胎儿腹腔内分别注射9×10⁵个新鲜细胞或按上述条件培养的细胞。尽管所有移植的胎羊骨髓(BM)中都显示有人细胞存在,但在无血清条件下培养3天然后再培养7天的细胞部分,在原代受体中获得了最高水平的长期植入。在二代绵羊受体中,从接受过无血清条件下培养3天的培养细胞的原代受体获得细胞的绵羊中,也实现了最高水平的长期植入。